Evidence map›Paper›PMID 37051190›Full record

ArticleJAC-antimicrobial resistance2023

Meningitis caused by extended-spectrum β-lactamase-producing

Gabriel Lignieres, Alexis Rybak, Corinne Levy, André Birgy, Stéphane Bechet, Stéphane Bonacorsi, Robert Cohen, Fouad Madhi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAC-antimicrobial resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Gabriel LignieresService de Pédiatrie Générale, Maladies Infectieuses et Médecine Interne, CHU Robert Debré, APHP, Paris, France.
Alexis RybakService des Urgences Pédiatriques, CHU Robert Debré, APHP, Paris, France.ORCID https://orcid.org/0000-0002-2898-3710
Corinne LevyGroupe de Pathologie Infectieuse Pédiatrique (GPIP) de la Société Française de Pédiatrie (SFP), Paris, France.ORCID https://orcid.org/0000-0002-1927-6360
André BirgyGroupe de Pathologie Infectieuse Pédiatrique (GPIP) de la Société Française de Pédiatrie (SFP), Paris, France.
Stéphane BechetAssociation Clinique et Thérapeutique Infantile du Val-de-Marne (ACTIV), Créteil, France.
Stéphane BonacorsiGroupe de Pathologie Infectieuse Pédiatrique (GPIP) de la Société Française de Pédiatrie (SFP), Paris, France.
Robert CohenGroupe de Pathologie Infectieuse Pédiatrique (GPIP) de la Société Française de Pédiatrie (SFP), Paris, France.
Fouad MadhiService de Pédiatrie Générale, Maladies Infectieuses et Médecine Interne, CHU Robert Debré, APHP, Paris, France.ORCID https://orcid.org/0000-0001-6816-5272
Assistance Publique – Hôpitaux de Paris · FRSociété Française de Cardiologie · FRAssociation Clinique et Thérapeutique Infantile du Val de Marne · FRUniversité Sorbonne Nouvelle · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: We report the first case series focusing on clinical and biological characteristics of meningitis caused by ESBL-producing Methods: Between 2001 and 2020, data on all cases of Results: In total, 548 cases of Conclusions: Meropenem seems to be the treatment of choice for ESBL-producing

Identifiers

PMID37051190
PMCPMC10083514
OpenAlexW4362735133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.